DOI: https://doi.org/10.26641/2307-0404.2018.1(part1).127253

Immunological aspects of cytomegalovirus infection in community-acquired pneumonia among young adults.

K. D. Chichirelo-Konstantynovych, L. V. Moroz, T. V. Konstantynovych, A. V. Demchuk

Abstract


The problem of comorbidities and mutual influence due to progressive immunological suppression occupies an important place in the morbidity structure among young population. This fact is usually considered to be a result of existent immunodeficiency in the process of studying respiratory comorbidities with subsequent chances of immunological reactivities. The purpose of our research is to investigate the features of immunological reactivity changes among young patients with community-acquired pneumonia and cytomegaloviral persistence. Received data showed a high level of cytomegaloviral persistence prevalence which increases the levels of cellular and humor immunodeficiency in patients with community-acquired pneumonia. Such influence on the immunity state is associated with the worse clinical course of CAP according to PORT-scale.


Keywords


community-acquired pneumonia; cytomegalovirus pneumonia; immunosuppression; PORT

References


Pokrovkiy VI, Tvorohova MH, Shypulin HA. [La­boratory diagnostics of infectious diseases]. Publi­shing house BINOM. 2013;648. Russian.

Melnik AA. [Clinical laboratory tests for practical me­dicine, their interpritation]. Kyiv, Kniga-plyus. 2011;288. Russian.

Moroz LV, Chichirello-Konstantinovich KD, Konstantynovych TV, Bondarchuk OB. [Characteristics of immunological status of patients with community-acquired pneumonia: the features of cytomegaloviral per­sistence]. Visnyk Vinnytskoho natsionalnoho medych­noho universytetu. 2015;19(2):423-8. Ukrainian.

Feshchenko YuI, Holubovska OA, Goncha­rov KA. [Community-acquired and nosocomial pneu­monia in adults: etiology, pathogenesis, classification, diagnostics, antibiotic therapy]. Metodychnyi posibnyk. 2014;122. Ukrainian.

Chichirello-Konstantinovich K, Konstantyno­vych T, Moroz L. Peculiarities of Immune Status among Young Patients with Community-Acquired Pneumonia (CAP) during Cytomegaloviral Persistence (CMVP). European Res­piratory Journal. 2017;50(suppl 61):PA987. doi: 10.1183/1393003 PA987

Goussard P, Kling S, Gie R, Nel E, Heyns L, Ros­souw G, & Janson J. CMV pneumonia in HIV-infected ven­tilated infants. Pediatric Pulmonology. 2010;45(7):650-5. http://dx.doi.org/10.1002/ppul.21228

Reeves M, Sinclair J. Aspects of human cytome­galovirus latency and reactivation. Curr. Top. Microbiol. Immunol. 2008;325:297-313.


GOST Style Citations


  1. Лабораторная диагностика инфекционных бо­лезней: Справочник / под ред. В.И. Покровского, М.Г. Тво­роговой, Г.А. Шипулина. – Москва: Изд-во БИНОМ, 2014. – С. 113-119.
  2. Мельник А.А. Клинические лабораторные тес­ты для практической медицины, их интерпретация / А.А. Мельник. – Киев: Книга-плюс, 2011. – 288 с.
  3. Негоспітальна та госпітальна (нозокоміальна) пневмонія у дорослих осіб: етіологія, патогенез, кла­сифікація, діагностика, антибактеріальна терапія: метод. посіб. / Ю.І. Фещенко [та ін.]. – Київ, 2013. – 122 с.
  4. Характеристика параметрів імунологічного статусу хворих негоспітальною пневмонією: особли­вості впливу персистуючої цитомегаловірусної інфек­ції / Л.В. Мороз, К.Д. Чічірельо-Константинович, Т.В. Константинович, О.Б. Бондарчук // Вісник Він­ниц. нац. мед. ун-ту. – 2015. – Т. 19, № 2. – С. 423-428.
  5. Chichirello-Konstantinovich  K. Peculiarities of Im­mune Status among Young Patients with Community-Acquired Pneumonia (CAP) during Cytomegaloviral Per­sistence (CMVP) / K. Chichirello-Konstantinovich, T. Konstantynovych, L. Moroz // Eur. Resp. J. –2017. – Vol. 50, Suppl 61. - PA987. doi: 10.1183/1393003 PA987
  6. CMV Pneumonia in HIV-Infected Ventilated In­fants / P. Goussard [et al.] // Pediat. Pulmonol. – 2010. – Vol. 45, N 7. – P. 650-655.
  7. Reeves M. Aspects of human cytomegalovirus la­ten­cy and reactivation / M. Reeves, J. Sinclair // Curr. Top. Microbiol. Immunol. - 2008. - Vol. 325. - P. 297–313.